Matsuda M - Search Results

1

Current status of remote radiotherapy treatment planning in Japan: findings from a national survey†.

Saito M, Tamamoto T, Kawashiro S, Umezawa R, Matsuda M, Tohyama N, Katsuta Y, Kanai T, Nemoto H, Onishi H. Saito M, et al. Among authors: matsuda m. J Radiat Res. 2024 Jan 19;65(1):127-135. doi: 10.1093/jrr/rrad085. J Radiat Res. 2024. PMID: 37996096 Free PMC article.

2

Dosimetric comparison of five different radiotherapy treatment planning approaches for locally advanced non-small cell lung cancer with sequential plan changes.

Saito M, Komiyama T, Marino K, Aoki S, Akita T, Matsuda M, Sano N, Suzuki H, Koji U, Nemoto H, Onishi H. Saito M, et al. Among authors: matsuda m. Thorac Cancer. 2023 Dec;14(35):3445-3452. doi: 10.1111/1759-7714.15137. Epub 2023 Oct 16. Thorac Cancer. 2023. PMID: 37846145 Free PMC article.

3

Liver parenchymal changes detected by MR elastography and diffusion-weighted imaging after stereotactic body radiotherapy for hepatocellular carcinoma.

Omiya Y, Morisaka H, Matsuda M, Saito M, Hashimoto T, Motosugi U, Onishi H. Omiya Y, et al. Among authors: matsuda m. Abdom Radiol (NY). 2023 Nov;48(11):3353-3361. doi: 10.1007/s00261-023-03995-x. Epub 2023 Aug 5. Abdom Radiol (NY). 2023. PMID: 37542553

4

Real-World Results of Stereotactic Body Radiotherapy for 399 Medically Operable Patients with Stage I Histology-Proven Non-Small Cell Lung Cancer.

Onishi H, Shioyama Y, Matsumoto Y, Matsuo Y, Miyakawa A, Yamashita H, Matsushita H, Aoki M, Nihei K, Kimura T, Ishiyama H, Murakami N, Nakata K, Takeda A, Uno T, Nomiya T, Taguchi H, Seo Y, Komiyama T, Marino K, Aoki S, Matsuda M, Akita T, Saito M. Onishi H, et al. Among authors: matsuda m. Cancers (Basel). 2023 Sep 1;15(17):4382. doi: 10.3390/cancers15174382. Cancers (Basel). 2023. PMID: 37686657 Free PMC article.

5

Identification and epidemiological study of an uncultured flavivirus from ticks using viral metagenomics and pseudoinfectious viral particles.

Kobayashi D, Inoue Y, Suzuki R, Matsuda M, Shimoda H, Faizah AN, Kaku Y, Ishijima K, Kuroda Y, Tatemoto K, Virhuez-Mendoza M, Harada M, Nishino A, Inumaru M, Yonemitsu K, Kuwata R, Takano A, Watanabe M, Higa Y, Sawabe K, Maeda K, Isawa H. Kobayashi D, et al. Among authors: matsuda m. Proc Natl Acad Sci U S A. 2024 May 7;121(19):e2319400121. doi: 10.1073/pnas.2319400121. Epub 2024 Apr 30. Proc Natl Acad Sci U S A. 2024. PMID: 38687787

6

Prospects of perfusion contrast-enhanced ultrasound (CE-US) in diagnosing axillary lymph node metastases in breast cancer: a comparison with lymphatic CE-US.

Mori N, Li L, Matsuda M, Mori Y, Mugikura S. Mori N, et al. Among authors: matsuda m. J Med Ultrason (2001). 2024 Apr 20. doi: 10.1007/s10396-024-01444-w. Online ahead of print. J Med Ultrason (2001). 2024. PMID: 38642268 Review.

7

New-onset of rheumatic diseases following COVID-19 vaccination: the report of three cases and a literature review.

Matsuda M, Funakubo Asanuma Y, Emoto K, Sakai S, Okumura N, Yazawa H, Maruyama T, Tsuzuki Wada T, Yokota K, Araki Y, Akiyama Y, Mimura T. Matsuda M, et al. Immunol Med. 2024 Apr 16:1-12. doi: 10.1080/25785826.2024.2339542. Online ahead of print. Immunol Med. 2024. PMID: 38627989

8

Exposure to urban ambient particles (PM2.5) before pregnancy affects the expression of endometrial receptive markers to embryo implantation in mice: Preliminary results.

de Castro KR, Almeida GHDR, Matsuda M, de Paula Vieira R, Martins MG, Rici REG, Saldiva PHN, Veras MM. de Castro KR, et al. Among authors: matsuda m. Tissue Cell. 2024 Mar 30;88:102368. doi: 10.1016/j.tice.2024.102368. Online ahead of print. Tissue Cell. 2024. PMID: 38583225

9

Human granulocytic anaplasmosis with rash and rhabdomyolysis: A case report.

Kawaguchi T, Rikitake Y, Rikitake M, Kimura M, Iwao C, Iwao K, Aizawa A, Sumiyoshi M, Kariya Y, Matsuda M, Miyauchi S, Umekita K, Takajo I, Ohashi N, Miyazaki T. Kawaguchi T, et al. Among authors: matsuda m. J Infect Chemother. 2024 Apr 2:S1341-321X(24)00109-0. doi: 10.1016/j.jiac.2024.04.001. Online ahead of print. J Infect Chemother. 2024. PMID: 38574814

10

Effects of aflibercept and bevacizumab on cell viability, cell metabolism and inflammation in hypoxic human Müller cells.

Matsuda M, da Silva RA, Roda VMP, Marquezini MV, Monteiro MLR, Hamassaki DE. Matsuda M, et al. PLoS One. 2024 Mar 27;19(3):e0300370. doi: 10.1371/journal.pone.0300370. eCollection 2024. PLoS One. 2024. PMID: 38536827 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,869 results

Search Page